Amorphous materials
Understand Amorphous Materials in 8 Minutes
September 02 by Niamh MadiganOne of the main challenges when working with Amorphous materials is being able to predict and characterise properties which are common to crystalline products. Yaroslav Khimyak, Professor in NMR at th...
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
July 27 by Pharma IQThe use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable drug properties and the latest findings from Pharma IQ suggest that many developers consider...
Investing in Techniques for Developing Amorphous Materials
February 13 by Pharma IQThe use of amorphous materials presents many opportunities for the pharmaceutical industry in terms of increased solubility and bioavailability, particularly as a growing number of insoluble active ph...
Implementing Thermal Processing Technologies for the Production of Amorphous Solid Dispersions
September 05 by Helen WinsorAmorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid state development. Dr. Dave Miller, Senior Principal Scientist at Hoffmann-La Roche, speaks to...
The Challenges of Amorphous Solid Dispersion Production: A Hoffman La Roche Perspective
July 11 by Pharma IQDr. Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise amorphous form selection, techniques to enhance amorphous drug performance and the best strategies...
Amorphous Material Studies: Collaboration, Commitment and Compliance
March 29 by Marc DescampsMarc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Pharma IQ to discuss the use of amorphous pha...